The use of transgenic mice for the production of a human monoclonal antibody specific for human CD69 antigen

Journal of Immunological Methods

Volumn 282, Issue 1-2, 2003, Pages 147-158

  Molina, Ana ^a   Valladares, Mónica ^a   Magadán, Susana ^a   Sancho, David ^b   Viedma, Fernando ^b   Sanjuan, Irene ^c   Gambón, Francisco ^c   Sánchez Madrid, Francisco ^b   González Fernández, África ^a  

^a UNIVERSITY OF VIGO   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c HOSPITAL DO MEIXOEIRO   (Spain)

Author keywords

Human CD69; Human monoclonal antibodies; Transgenic mice

Indexed keywords

CALCIUM; CD69 ANTIGEN; HUMAN MONOCLONAL ANTIBODY; HUMAN MONOCLONAL ANTIBODY AIM 29; IMMUNOGLOBULIN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; PHORBOL 13 ACETATE 12 MYRISTATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN RECOGNITION; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL CLONING; CELL FUSION; CELL HYBRIDIZATION; CELL PROLIFERATION; CONTROLLED STUDY; CROSS LINKING; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNIZATION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LEUKOCYTE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSGENE; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 0242352673     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2003.08.007     Document Type: Article

References (33)

1. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
2. Brüggemann M., Neuberger M.S. Strategies for expressing human antibody repertoires in transgenic mice. Immunol. Today. 17:1996;391-397.
3. Brüggemann M., Taussig M.J. Production of human antibody repertoire in transgenic mice. Curr. Opin. Biotechnol. 8:1997;455-458.
4. Cebrián M., Yagüe E., Rincón M., López-Botet M., de Landázuri M.O., Sánchez-Madrid F. Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J. Exp. Med. 168:1988;1621-1637.
5. Conde M., Montano R., Moreno-Aurioles V.R., Ramirez R., Sánchez-Mateos P., Sánchez-Madrid F., Sobrino F. Anti-CD69 antibodies enhance phorbol-dependent glucose metabolism and Ca2+ levels in human thymocytes. Antagonist effect of cyclosporin A. J. Leukoc. Biol. 60:1996;278-284.
6. Crispín J.C., Martínez A., de Pablo P., Velasquillo C., Alcocer-Varela J. Participation of the CD69 antigen in the T-cell activation process of patients with systemic lupus erythematosus. Scand. J. Immunol. 48:1998;196-200.
7. Erlanson M., Grönlund E., Löfvenberg E., Roos G., Lindh J. Expression of activation markers CD23 and CD69 in B-cell non-Hodgkin's lymphoma. Eur. J. Haematol. 60:1998;125-132.
8. Esplugues E., Sancho D., Vega-Ramos J., Martínez C., Syrbe U., Hamann A., Engel P., Sánchez-Madrid F., Lauzurica P. Enhanced antitumor immunity in mice deficient in CD69. J. Exp. Med. 197:2003;1093-1106.
9. García-Monzón C., Moreno-Otero R., Pajares J.M., García-Sánchez A., López-Botet M., de Landázuri M.O., Sánchez-Madrid F. Expression of a novel activation antigen on intrahepatic CD8+ T lymphocytes in viral chronic active hepatitis. Gastroenterology. 98:1990;1029-1035.
10. Gessl A., Waldhäusl W. Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing. J. Clin. Endocrinol. Metab. 83:1998;2204-2209.
11. Hartnell A., Robinson D.S., Kay A.B., Wardlaw A.J. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunology. 80:1993;281-286.
12. Harwood S.J., Valdivia S., Hung G.L., Quenzer R.W. Use of Sulesomab, a radiolabeled antibody fragment, to detect osteomyelitis in diabetic patients with foot ulcers by leukoscintigraphy. Clin. Infect. Dis. 6:1999;1200-1205.
13. Iannone F., Corrigal V.M., Panayi G.S. CD69 on synovial T cells in rheumatoid arthritis correlates with disease activity. Br. J. Rheumatol. 39:1996;397.
14. Jakobovits A. Production of fully human antibodies by transgenic mice. Curr. Opin. Biotechnol. 6:1995;561-566.
15. Kitamura D., Roes J., Kuhn R., Rajewsky K. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature. 350:1991;423-426.
16. Klee G.G. Human anti-mouse antibodies. Arch. Pathol. Lab. Med. 124:2000;921-923.
17. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of redefined specificity. Nature. 256:1975;495-497.
18. Laffón A., García-Vicuña R., Humbría A., Postigo A.A., Corbí A.L., de Landázuri M.O., Sánchez- Madrid F. Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis. J. Clin. Invest. 88:1991;546-552.
19. Lanier L.L., Buck D.W., Rhodes L., Ding A., Evans E., Barney C., Phillips J.H. Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J. Exp. Med. 167:1988;1572-1585.
20. Linenberger M.L., Maloney D.G., Bernstein I.D. Antibody directed therapies for hematological malignancies. Trends Mol. Med. 8:2002;69-76.
21. Llera A.S., Viedma F., Sánchez-Madrid F., Tormo J. Crystal structure of the C-type lectin-like domain from the human hematopoietic cell receptor CD69. J. Biol. Chem. 276:2001;7312-7319.
22. López-Cabrera M., Santis A.G., Fernández-Ruiz E., Balcher R., Esch F., Sánchez-Mateos P., Sánchez-Madrid F. Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J. Exp. Med. 178:1993;537-547.
23. Magadán S., Valladares M., Suarez E., Sanjuan I., Molina A., Ayling C., Davies S., Zou X., Williams G.T., Neuberger M.S., Brüggemann M., Gambón F., Díaz-Espada F., González-Fernández A. Production of antigen-specific human monoclonal antibodies from translocus mice: comparison of mice carrying IgH/kappa or IgH/kappa/lambda transloci. BioTechniques. 33:2002;680-690.
24. Murata K., Inami M., Hasegawa A., Kubo S., Kimura M., Yamashita M., Hosokawa H., Nagao T., Suzuki K., Hashimoto K., Shinkai H., Koseki H., Taniguchi M., Ziegler S.F., Nakayama T. CD69-null mice protected from arthritis induced with anti-type II collagen antibodies. Int. Immunol. 15:2003;987-992.
25. Nicholson I.C., Zou X., Popov A.V., Cook G.P., Corps E.M., Humphries S., Ayling C., Goyenechea B., Xian J., Taussig M.J., Neuberger M.S., Brüggemann M. Antibody repertoires of four- and five-feature translocus mice carrying human immunoglobulin heavy chain and kappa and lambda light chain yeast artificial chromosomes. J. Immunol. 163:1999;6898-6909.
26. Sancho D., Santis A.G., Alonso-Lebrero J.L., Viedma F., Tejedor R., Sánchez-Madrid F. Functional analysis of ligand-binding and signal transduction domains of CD69 and CD23 C-type lectin leukocyte receptors. J. Immunol. 165:2000;3868-3875.
27. Santis A.G., Campanero M.R., Alonso J.L., Tugores A., Alonso M.A., Yagüe E., Pivel J.P., Sánchez-Madrid F. Tumor necrosis factor-alpha production induced in T lymphocytes through the AIM/CD69 activation pathway. Eur. J. Immunol. 22:1992;1253-1259.
28. Santis A.G., López-Cabrera M., Hamann J., Strauss M., Sánchez-Madrid F. Structure of the gene coding for the human early lymphocyte activation antigen CD69: a C-type lectin receptor evolutionarily related with the gene families of natural killer cell-specific receptors. Eur. J. Immunol. 24:1994;1692-1697.
29. Testi R., Phillips J.H., Lanier L.L. T cell activation via Leu-23 (CD69). J. Immunol. 143:1989;1123-1128.
30. Vaughan T.J., Osbourn J.K., Tempest P.R. Human antibodies by design. Nat. Biotechnol. 16:1998;535-539.
31. Wagner S.D., Popov A.V., Davies S.L., Xian J., Neuberger M.S., Brüggemann M. The diversity of antigen-specific monoclonal antibodies from transgenic mice bearing human immunoglobulin gene miniloci. Eur. J. Immunol. 24:1994;2672-2681.
32. Ziegler S., Ramsdell F., Hjerrild K.A., Armitage R.J., Grabstein K.H., Hennen K.B., Farrah T., Fanslow W.C., Shevach E.M., Anderson M.R. Molecular characterization of the early activation antigen CD69: a type II membrane glycoprotein related to a family of natural killer cell activation antigens. Eur. J. Immunol. 23:1993;1643-1648.
33. Zou X., Xian J., Popov A.V., Rosewell I.R., Muller M., Brüggemann M. Subtle differences in antibody responses and hypermutation of lambda light chains in mice with a disrupted chi constant region. Eur. J. Immunol. 25:1995;2154-2162.